The StrataTest® human skin model, a consistent in vitro alternative for toxicological testing

Toxicology in Vitro

Volumn 24, Issue 7, 2010, Pages 2021-2029

  Rasmussen, Cathy ^a   Gratz, Ken ^a   Liebel, Frank ^b   Southall, Michael ^b   Garay, Michelle ^b   Bhattacharyya, Surjya ^b   Simon, Nick ^a   Zanden, Marie Vander ^a   Winkle, Kelly Van ^a   Pirnstill, John ^a   Pirnstill, Sara ^a   Comer, Allen ^a   Allen Hoffmann, B Lynn ^a  

^a Stratatech Corporation   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

Dermal toxicology testing; Full thickness skin tissue; Human skin model; In vitro alternative to animal testing

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; IRRITANT AGENT; OZONE; PARTHENOLIDE; REACTIVE OXYGEN METABOLITE; SUNSCREEN; THYMIDINE;

ARTICLE; BIOLOGICAL MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; SKIN CONDUCTANCE; SKIN PERMEABILITY; SKIN TOXICITY; SMOKE; TOXICITY TESTING; ULTRAVIOLET RADIATION;

ANIMAL TESTING ALTERNATIVES; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, BIOLOGICAL; OZONE; REACTIVE OXYGEN SPECIES; REFRIGERATION; SKIN; SUNSCREENING AGENTS; TOBACCO SMOKE POLLUTION; TOXICITY TESTS; ULTRAVIOLET RAYS;

ANIMALIA; TANACETUM PARTHENIUM;

EID: 77957017334     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.07.027     Document Type: Article

References (47)

1. Allen-Hoffmann B.L., et al. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Invest. Dermatol. 2000, 114(3):444-455.
2. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur. J. Dermatol. 2003, 13(6):515-523.
3. Basketter D.A., York M., McFadden J.P., Robinson M.K. Determination of skin irritation potential in the human 4-h patch test. Contact Dermatitis 2004, 51(1):1-4.
4. Bernhofer L.P., Seiberg M., Martin K. The influence of the response of skin equivalent systems to topically applied consumer products by epithelial-mesenchymal interactions. Toxicol. In Vitro 1999, 13(2):219-229.
5. Bilimoria M.H., Ecobichon D.J. Protective antioxidant mechanisms in rat and guinea pig tissues challenged by acute exposure to cigarette smoke. Toxicology 1992, 72(2):131-144.
6. Botham P.A., Earl L.K., Fentem J.H., Roguet R., van de Sandt J.J.M. Alternative methods for skin irritation testing: the current status. Altern. Lab. Anim. 1998, 26(2):195-211.
7. Cotovio J., Onno L., Justine P., Lamure S., Catroux P. Generation of oxidative stress in human cutaneous models following in vitro ozone exposure. Toxicol. In Vitro 2001, 15(4-5):357-362.
8. de Fraissinette A., et al. Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles. Cell Biol. Toxicol. 1999, 15:121-135.
9. ECVAM, 2007a. ECVAM SIVS: performance standards for applying human skin models to in vitro skin irritation testing.
10. ECVAM, 2007b. Statement on the validity of in vitro tests for skin irritation.
11. Fagot D., Asselineau D., Bernerd F. Matrix metalloproteinase-1 production observed after solar-simulated radiation exposure is assumed by dermal fibroblasts but involves a paracrine activation through epidermal keratinocytes. Photochem. Photobiol. 2004, 79(6):499-505.
12. Foth H., Hayes A. Concept of REACH and impact on evaluation of chemicals. Hum. Exp. Toxicol. 2008, 27(1):5-21.
13. Gabard B., Treffel P. Hardware and measuring principle: the Nova DPM 9003. Bioengineering of the Skin: Water and the Stratum Corneum 1994, 177-195. CRC Press, Boca Raton. P. Elsner, E. Berardesca, H.I. Maibach (Eds.).
14. Goretsky M.J., Supp A.P., Greenhalgh D.G., Warden G.D., Boyce S.T. Surface electrical capacitance as an index of epidermal barrier properties of composite skin substitutes and skin autografts. Wound Repair Regen. 1995, 3:419-425.
15. Groenewegen W.A., Knight D.W., Heptinstall S. Progress in the medicinal chemistry of the herb feverfew. Prog. Med. Chem. 1992, 29:217-238.
16. Hartung T. Toxicology for the twenty-first century. Nature 2009, 460(7252):208-212.
17. Hartung T., Rovida C. Chemical regulators have overreached. Nature 2009, 460(7259):1080-1081.
18. Hausen B.M., Osmundsen P.E. Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species. Acta Derm. Venereol. 1983, 63(4):308-314.
19. Heptinstall S. Feverfew - an ancient remedy for modern times?. J. R. Soc. Med. 1988, 81(7):373-374.
20. Hofer T., et al. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Arch. Toxicol. 2004, 78(10):549-564.
21. Jain N.K., Kulkarni S.K. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J. Ethnopharmacol. 1999, 68(1-3):251-259.
22. Kwok B.H., Koh B., Ndubuisi M.I., Elofsson M., Crews C.M. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem. Biol. 2001, 8(8):759-766.
23. Ling G., et al. Epidermal p53 response and repair of thymine dimers in human skin after a single dose of ultraviolet radiation: effects of photoprotection. Acta Derm. Venereol. 2001, 81(2):81-86.
24. Magnusson M., Papini R.P., Rea S.M., Reed C.C., Wood F.M. Cultured autologous keratinocytes in suspension accelerate epithelial maturation in an in vivo wound model as measured by surface electrical capacitance. Plast. Reconstr. Surg. 2007, 119(2):495-499.
25. Martin K., et al. Parthenolide-depleted Feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression. Arch. Dermatol. Res. 2008, 300(2):69-80.
26. Muller T., Gebel S. Heme oxygenase expression in Swiss 3T3 cells following exposure to aqueous cigarette smoke fractions. Carcinogenesis 1994, 15(1):67-72.
27. Nakajima S., et al. UV light-induced DNA damage and tolerance for the survival of nucleotide excision repair-deficient human cells. J. Biol. Chem. 2004, 279(45):46674-46677.
28. Netzlaff F., et al. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur. J. Pharm. Biopharm. 2005, 60(2):167-178.
29. CD O.E. Draft Guidance Notes for the Estimation of Dermal Absorption Values. Environmental Directorate: Organisation for Economic Co-operation and Development 2008, Paris, FR.
30. Pathak H.D., Pant H.C., Pal M. Effect of UV radiation on amino acids. I. Preliminary studies of UV radiation induced changes in aqueous solution of methionine. Indian J. Biochem. 1968, 5(2):65-68.
31. Paulsen E., Christensen L.P., Andersen K.E. Compositae dermatitis from airborne parthenolide. Br. J. Dermatol. 2007, 156(3):510-515.
32. Perkins M.A., Osborne R., Rana F.R., Ghassemi A., Robinson M.K. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Toxicol. Sci. 1999, 48:218-229.
33. Pinkus H. Examination of the epidermis by the strip method of removing horny layers. I. Observations on thickness of the horny layer, and on mitotic activity after stripping. J. Invest. Dermatol. 1951, 16(6):383-386.
34. Rovida, C., Hartung, T., (Eds.), 2009. Re-evaluation of Animal Numbers and Costs for In Vivo Tests to Accomplish REACH Legislation Requirements for Chemicals... Transatlantic Think Tank for Toxicology.
35. Schurr M.J., et al. Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. J. Trauma 2009, 66(3):866-873.
36. Schwarz T. The significance of epidermal cytokines in UV-induced immune suppression. Hautarzt 1988, 39(10):642-646.
37. Smola H., et al. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp. Cell Res. 1998, 239(2):399-410.
38. Sur R., et al. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium). Inflammopharmacology 2009, 17(1):42-49.
39. Thiele J.J., et al. Ozone depletes tocopherols and tocotrienols topically applied to murine skin. FEBS Lett. 1997, 401(2-3):167-170.
40. Thiele J.J., Traber M.G., Tsang K., Cross C.E., Packer L. In vivo exposure to ozone depletes vitamins C and E and induces lipid peroxidation in epidermal layers of murine skin. Free Radic. Biol. Med. 1997, 23(3):385-391.
41. Tweats D.J., Scott A.D., Westmoreland C., Carmichael P.L. Determination of genetic toxicity and potential carcinogenicity in vitro-challenges post the Seventh Amendment to the European Cosmetics Directive. Mutagenesis 2007, 22(1):5-13.
42. Valacchi G., et al. Induction of stress proteins and MMP-9 by 0.8ppm of ozone in murine skin. Biochem. Biophys. Res. Commun. 2003, 305(3):741-746.
43. Valacchi G., et al. Ozone exposure activates oxidative stress responses in murine skin. Toxicology 2002, 179(1-2):163-170.
44. Van de Sandt J.J., et al. The use of human keratinocytes and human skin models for predicting skin irritation: the report and recommendations of ECVAM workshop 38. Altern. Lab. Anim. 1999, 27:723-743.
45. van der Valk P.G., Maibach H.I. A functional study of the skin barrier to evaporative water loss by means of repeated cellophane-tape stripping. Clin. Exp. Dermatol. 1990, 15(3):180-182.
46. Werner S., Krieg T., Smola H. Keratinocyte-fibroblast interactions in wound healing. J. Invest. Dermatol. 2007, 127(5):998-1008.
47. Worth A.P., Cronin M.T. The use of bootstrap resampling to assess the variability of Draize tissue scores. Altern. Lab. Anim. 2001, 29(5):557-573.